Updates

At the BIO-SEE 2023 Webinar Series, Damian Wheeler Ph.D., CEO of Translucence Biosystems, presented the company's innovative approach to brain-wide single-cell imaging in a talk entitled "Brain-wide single-cell resolution imaging and machine learning-enabled quantification".

Our team has been working with Lundbeck to monitor therapeutic antibody biodistribution in the brain using tissue clearing and light sheet imaging. Our CEO, Damian Wheeler, Ph.D. presented our findings in our poster titled the "Brain-Wide Cellular-Resolution Measurement of Antibody Therapeutics."

Translucence Biosystems was proud to sponsor the 20th Annual Advanced Imaging Methods Workshop, an event that brought together researchers and industry leaders to share the latest advancements in imaging technology.

Sunil Gandhi Ph.D. discusses novel imaging technology that has the potential to dramatically enhance how researchers can locate drug effects in the central nervous system (CNS) for preclinical studies.

UCI Beall Applied Innovation recently recognized nominees and awardees, virtually, at the third annual UC Irvine Innovator Awards.

We are excited to announce that Translucence Biosystems has entered into a collaborative and strategic relationship with Carl Zeiss AG to promote the use of the Mesoscale Imaging SystemTM with the new ZEISS Lightsheet 7 microscope, designed to advance the 3D histology revolution.